• Summary of FDA Advertising and Promotion Enforcement Activities - August 2010
  • November 11, 2010 | Authors: Ellen J. Flannery; Richard F. Kingham; Michael S. Labson; Erika Lietzan; Peter O. Safir
  • Law Firm: Covington & Burling LLP - Washington Office
  • This e-alert is part of a monthly series of e-alerts summarizing publicly-available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of drugs, biologics, and medical devices. In August 2010, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) posted the following three untitled letters on its website: